<DOC>
	<DOCNO>NCT01545219</DOCNO>
	<brief_summary>Healthy volunteer recruit study give four different treatment 28 week period . These treatment include : prebiotic , probiotic , synbiotic ( prebiotic + probiotic ) placebo . Faecal sample , blood saliva collect analysed change faecal microbial population select immune response .</brief_summary>
	<brief_title>A Study Prebiotic , Probiotic Synbiotic Upon Gut Microbiota Immune Response Healthy Volunteers</brief_title>
	<detailed_description>The primary objective study determine effect XOS ( administer 8g/day ) , B. lactis BI07 ( administer 109 CFU/day ) synbiotic combination ( 8g/day XOS 109 CFU/day B. lactis BI07 ) human gut microbiota . A double-blind , placebo-controlled , randomize crossover study conduct 44 healthy volunteer . The placebo maltodextrin ( food grade ingredient , administer 8g/day ) . Changes gut microbiota determine measure bacterial population level human faeces use fluorescence situ hybridisation ( FISH ) 16S rRNA target oligonucleotide probe . Concentrations short chain fatty acid ( SCFA ) quantify use gas chromatography ( GC ) . In addition analysis perform sample University Reading , analyse microbial metabolite select member microbiota also perform Danisco Finland , Kantvik . University Reading therefore provide Danisco Kantvik faecal sample appropriate size . The secondary objective study examine effect XOS ( 8g/day ) , B. lactis BI07 ( 109 CFU/day ) synbiotic ( 8g/day XOS 109 CFU/day B. lactis BI07 ) bowel function , immune function plasma lipids 44 healthy volunteer . This achieve use volunteer diary bowel function mood , investigate total plasma lipid , mucosal immunity ( salivary faecal IgA ) , total leukocyte number , expression cell surface marker immune cell identify cell subset activation marker , production inflammatory marker whole blood culture , plasma chemokines , phagocytosis oxidative burst monocyte granulocyte , plasma/serum immunoglobulin , acute phase protein , complement protein soluble adhesion molecule .</detailed_description>
	<criteria>sign consent form age 2565 year body mass index 2030 inclusive good general health determine medical questionnaire additional inclusion criterion : far possible , target volunteer group mild constipation ( bowel movement less 1/day , hard stool consistency ) â€¢ Evidence physical mental disease plan major surgery , might limit participation completion study History drug abuse , include alcohol Severe allergy history severe abnormal drug reaction Participation experimental drug trial within four week prior study Participation prebiotics laxative trial within previous three month Use antibiotic within previous six month Chronic constipation , diarrhoea chronic gastrointestinal complaint Intake prebiotics probiotic , drug active gastrointestinal motility , laxative class four week prior study Use prescribed medication Regular use aspirin antiinflammatory drug</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>